Chemical Works of Gedeon Richter PLC RGEDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $35.75
- Day Range
- $35.75–38.12
- 52-Week Range
- $29.23–45.28
- Bid/Ask
- $23.37 / $59.47
- Shares Outstanding
- 182.39M
- Market Cap
- $6.77B
- Volume/Avg
- 174 / 508
Key Statistics
- Price/Earnings (Normalized)
- 10.89
- Price/Sales
- 2.41
- Dividend Yield (Trailing)
- 5.68%
- Dividend Yield (Forward)
- 5.68%
- Dividend Payment Schedule
- Jun
- Total Yield
- 5.77%
Company Profile
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women’s Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 11,955
- Website
- https://www.gedeonrichter.com
Valuation
|
Metric
|
RGEDF
|
|---|---|
Price/Earnings (Normalized) | 10.89 |
Price/Book Value | 1.55 |
Price/Sales | 2.41 |
Price/Cash Flow | 7.39 |
Price/Earnings
RGEDF
Financial Strength
|
Metric
|
RGEDF
|
|---|---|
Quick Ratio | 2.51 |
Current Ratio | 3.79 |
Interest Coverage | 24.08 |
Quick Ratio
RGEDF
Profitability
|
Metric
|
RGEDF
|
|---|---|
Return on Assets (Normalized) | 12.94% |
Return on Equity (Normalized) | 15.92% |
Return on Invested Capital (Normalized) | 15.07% |
Return on Assets
RGEDF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|sP#nSS$ | LOCK|Xmk^ | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|rcf@b$c? | LOCK|tn@^ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|!>Q!p& | LOCK|HDC | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|TgyjYhF% | LOCK|F<q | $31B | |||
| Viatris Inc
VTRS
| LOCK|&<Nd>l< | LOCK|>v | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|xWY | LOCK|d% | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Jm>C??! | LOCK|&lY | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|?LB#c> | LOCK|csf | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|^HQ!Hs | LOCK|Z>x& | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|XPzDCz< | LOCK|@w | $2B |
United States